Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingGlobeNewsWire • 11/03/23
Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and WebcastGlobeNewsWire • 10/19/23
Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in MiceGlobeNewsWire • 10/17/23
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 10/16/23
Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PHGlobeNewsWire • 10/16/23
Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsGlobeNewsWire • 10/04/23
Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities ConferenceGlobeNewsWire • 10/02/23
Beyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual MeetingGlobeNewsWire • 09/27/23
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum DisorderGlobeNewsWire • 09/18/23
Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific RegionGlobeNewsWire • 09/07/23
Beyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference Call and WebcastGlobeNewsWire • 07/24/23
Beyond Air® Reports Financial Results for Fourth Quarter and Fiscal Year-End 2023GlobeNewsWire • 06/22/23
Beyond Air® Schedules Fiscal Year End 2023 Financial Results Conference Call and WebcastGlobeNewsWire • 05/16/23
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the American Association for Cancer Research (AACR) 2023 Annual MeetingGlobeNewsWire • 04/19/23